Australia markets closed

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
81.80-1.75 (-2.09%)
At close: 04:00PM EST
82.01 +0.21 (+0.26%)
After hours: 07:58PM EST
Full screen
Trade prices are not sourced from all markets
Previous close83.55
Open84.50
Bid81.84 x 900
Ask82.00 x 1100
Day's range79.02 - 85.45
52-week range41.60 - 189.89
Volume509,213
Avg. volume465,929
Market cap2.44B
Beta (5Y monthly)N/A
PE ratio (TTM)4.29
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    Fulgent Genetics Confirms Ability to Detect Omicron Variant with RT-PCR Tests for COVID-19

    TEMPLE CITY, Calif., December 01, 2021--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent" or the "Company"), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today confirmed that the Company’s RT-PCR test for SARS-CoV-2, the virus that causes COVID-19, can successfully detect the recently emerged Omicron variant of the virus. In addition, Fulgent is confident that its Next Generation Sequencing (NGS

  • Business Wire

    Fulgent Genetics Reports Third Quarter Financial Results

    TEMPLE CITY, Calif., November 09, 2021--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent Genetics" or the "company"), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today announced financial results for its third quarter ended September 30, 2021.

  • Business Wire

    Representatives of Fulgent Genetics to Participate in Upcoming Virtual Conferences

    TEMPLE CITY, Calif., November 09, 2021--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent Genetics" or the "company"), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today announced that members of its management team are scheduled to virtually participate in the following investor conferences: